Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dexcom Kiboshes Insulet Merger Rumors

Executive Summary

Bloomberg reported on 23 May that Dexcom is considering acquiring Insulet to become a diabetes tech giant. Dexcom said on 31 May that it is not in “active discussions” about a merger with anyone right now.

You may also be interested in...



Minute Insight: Insulet Launches Omnipod 5 US-Wide Following Trial Period

After six months, the Omnipod 5 has seen its limited market launch expanded to cover the entirety of the US market.

ADA 2022 Wrap Up: Iterative Progress On Glucose Control, No Big Surprises

The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.

Dexcom Rumored To Be In Talks To Acquire Insulet

Dexcom may be planning to purchase Insulet to enter the insulin pump market and transform itself into a diabetes tech giant.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel